Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

The prevalence and prognostic value of BRAF mutation in thyroid cancer.

Kebebew E, Weng J, Bauer J, Ranvier G, Clark OH, Duh QY, Shibru D, Bastian B, Griffin A.

Ann Surg. 2007 Sep;246(3):466-70; discussion 470-1.

PMID:
17717450
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

BRAF mutation in papillary thyroid carcinoma: pathogenic role and clinical implications.

Tang KT, Lee CH.

J Chin Med Assoc. 2010 Mar;73(3):113-28. doi: 10.1016/S1726-4901(10)70025-3. Review.

PMID:
20230995
[PubMed - indexed for MEDLINE]
3.

BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis.

Tufano RP, Teixeira GV, Bishop J, Carson KA, Xing M.

Medicine (Baltimore). 2012 Sep;91(5):274-86. doi: 10.1097/MD.0b013e31826a9c71. Review.

PMID:
22932786
[PubMed - indexed for MEDLINE]
4.

Detection of BRAF V600E activating mutation in papillary thyroid carcinoma using PCR with allele-specific fluorescent probe melting curve analysis.

Rowe LR, Bentz BG, Bentz JS.

J Clin Pathol. 2007 Nov;60(11):1211-5. Epub 2007 Feb 13. Review.

PMID:
17298986
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

[BRAF initiating mutations in the papillary thyroid carcinoma].

Rusinek D, GubaƂa E.

Endokrynol Pol. 2006 Jul-Aug;57(4):438-44. Review. Polish.

PMID:
17006850
[PubMed - indexed for MEDLINE]
6.

The utility of BRAF testing in the management of papillary thyroid cancer.

Melck AL, Yip L, Carty SE.

Oncologist. 2010;15(12):1285-93. doi: 10.1634/theoncologist.2010-0156. Epub 2010 Dec 8. Review.

PMID:
21147872
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Papillary thyroid carcinoma variants.

Lloyd RV, Buehler D, Khanafshar E.

Head Neck Pathol. 2011 Mar;5(1):51-6. doi: 10.1007/s12105-010-0236-9. Epub 2011 Jan 8. Review.

PMID:
21221869
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

BRAF(V600E) and microenvironment in thyroid cancer: a functional link to drive cancer progression.

Nucera C, Lawler J, Parangi S.

Cancer Res. 2011 Apr 1;71(7):2417-22. doi: 10.1158/0008-5472.CAN-10-3844. Epub 2011 Mar 29. Review.

PMID:
21447745
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Targeting BRAF in thyroid cancer.

Espinosa AV, Porchia L, Ringel MD.

Br J Cancer. 2007 Jan 15;96(1):16-20. Epub 2006 Dec 19. Review.

PMID:
17179987
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

To BRAF or not to BRAF: is that even a question anymore?

Horbinski C.

J Neuropathol Exp Neurol. 2013 Jan;72(1):2-7. doi: 10.1097/NEN.0b013e318279f3db. Review.

PMID:
23242278
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Progress in molecular-based management of differentiated thyroid cancer.

Xing M, Haugen BR, Schlumberger M.

Lancet. 2013 Mar 23;381(9871):1058-69. doi: 10.1016/S0140-6736(13)60109-9. Epub 2013 Mar 22. Review.

PMID:
23668556
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Identification and treatment of aggressive thyroid cancers. Part 1: subtypes.

Sturgeon C, Angelos P.

Oncology (Williston Park). 2006 Mar;20(3):253-60. Review.

PMID:
16629257
[PubMed - indexed for MEDLINE]
Free Article
13.

Thyroid cancer gender disparity.

Rahbari R, Zhang L, Kebebew E.

Future Oncol. 2010 Nov;6(11):1771-9. doi: 10.2217/fon.10.127. Review.

PMID:
21142662
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk